News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioCryst Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
·
12 min read
Biotech Beach
The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna
March 6, 2007
·
1 min read
Biotech Beach
The Week In Review: Biotech Ends Q3 With A Bang
October 3, 2006
·
1 min read
Biotech Beach
The Day In Review: Amgen Buys Avidia, Inc. For $290 Million
October 3, 2006
·
1 min read
Biotech Bay
The Day In Review: Amgen Gets Approval For Vectibix
September 27, 2006
·
1 min read
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
·
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Obesity Compound From Bayer Corporation
June 14, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
January 13, 2025
·
8 min read
Press Releases
BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 6, 2025
January 7, 2025
·
1 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2024
December 5, 2024
·
1 min read
Press Releases
BioCryst Launches ORLADEYO® (berotralstat) in Ireland
November 18, 2024
·
5 min read
Press Releases
BioCryst to Present at Upcoming Investor Conferences
November 6, 2024
·
1 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 5, 2024
·
1 min read
Press Releases
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
November 5, 2024
·
16 min read
Press Releases
BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)
October 25, 2024
·
11 min read
Press Releases
BioCryst to Report Third Quarter 2024 Financial Results on November 4
October 21, 2024
·
1 min read
